Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow
Background: Adiponectin, an adipocyte-secreted hormone involved in energy homeostasis, has broad anti-inflammatory, antioxidant, and endothelium- and myocardial-protective effects, together with a potentially positive regulatory function in coronary microcirculation. Although the physiological role...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Interna Publishing
2020-02-01
|
| Series: | Acta Medica Indonesiana |
| Subjects: | |
| Online Access: | https://www.actamedindones.org/index.php/ijim/article/view/1237 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849712803113336832 |
|---|---|
| author | Muhammad Diah Aznan Lelo Dharma Lindarto Zulfikri Mukhtar |
| author_facet | Muhammad Diah Aznan Lelo Dharma Lindarto Zulfikri Mukhtar |
| author_sort | Muhammad Diah |
| collection | DOAJ |
| description | Background: Adiponectin, an adipocyte-secreted hormone involved in energy homeostasis, has broad anti-inflammatory, antioxidant, and endothelium- and myocardial-protective effects, together with a potentially positive regulatory function in coronary microcirculation. Although the physiological role of adiponectin has not yet been fully elucidated, it may well be involved in the regulation of many of the inflammatory processes or lipid metabolisms that contribute to atherosclerosis. In this study we investigate the plasma concentration of adiponectin in patients with coronary artery disease (CAD), those with coronary slow flow (CSF) and in healthy subjects. Methods: this study was conducted according to a cross-sectional design involving 30 CAD, 30 CSF, and 30 healthy subjects. These subjects were sourced from the Dr. Zainoel Abidin Center Hospital, Banda Aceh, Indonesia, between December 2017 and February 2018. The plasma concentration of adiponectin was measured using enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s specifications.
Results: there were statistically significant differences at p<0.001 between the CAD, CSF, and healthy-subject groups in terms of age, sex, systolic blood pressure, total cholesterol, triglycerides, and creatinine. Mean plasma concentrations of adiponectin in patients with CAD were significantly lower than in patients with CSF and in healthy subjects (CAD: 3.40 (0.87) μg/ml; CSF: 4.58 (2.32) μg/ml; healthy subjects: 5.65 (4.87) μg/ml; P<0.001). Conclusion: the findings suggest that low plasma adiponectin concentration is associated with atherosclerosis. Plasma concentrations of adiponectin may be related to the pathophysiology role of cardiovascular disease in both CAD and CSF patients. |
| format | Article |
| id | doaj-art-0f1f67f6c44e4c21a4222ffe4c1663a8 |
| institution | DOAJ |
| issn | 0125-9326 2338-2732 |
| language | English |
| publishDate | 2020-02-01 |
| publisher | Interna Publishing |
| record_format | Article |
| series | Acta Medica Indonesiana |
| spelling | doaj-art-0f1f67f6c44e4c21a4222ffe4c1663a82025-08-20T03:14:09ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322020-02-01514Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow FlowMuhammad Diah0Aznan Lelo1Dharma Lindarto2Zulfikri Mukhtar3Faculty of Medicine, Universitas Sumatera Utara, Medan, IndonesiaDepartment of Pharmacology, Faculty of Medicine Universitas Sumatera Utara, Medan, IndonesiaDepartment of Internal Medicine, Faculty of Medicine Universitas Sumatera Utara, Medan, IndonesiaDepartment of Cardiology, Faculty of Medicine Universitas Sumatera Utara, Medan, IndonesiaBackground: Adiponectin, an adipocyte-secreted hormone involved in energy homeostasis, has broad anti-inflammatory, antioxidant, and endothelium- and myocardial-protective effects, together with a potentially positive regulatory function in coronary microcirculation. Although the physiological role of adiponectin has not yet been fully elucidated, it may well be involved in the regulation of many of the inflammatory processes or lipid metabolisms that contribute to atherosclerosis. In this study we investigate the plasma concentration of adiponectin in patients with coronary artery disease (CAD), those with coronary slow flow (CSF) and in healthy subjects. Methods: this study was conducted according to a cross-sectional design involving 30 CAD, 30 CSF, and 30 healthy subjects. These subjects were sourced from the Dr. Zainoel Abidin Center Hospital, Banda Aceh, Indonesia, between December 2017 and February 2018. The plasma concentration of adiponectin was measured using enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s specifications. Results: there were statistically significant differences at p<0.001 between the CAD, CSF, and healthy-subject groups in terms of age, sex, systolic blood pressure, total cholesterol, triglycerides, and creatinine. Mean plasma concentrations of adiponectin in patients with CAD were significantly lower than in patients with CSF and in healthy subjects (CAD: 3.40 (0.87) μg/ml; CSF: 4.58 (2.32) μg/ml; healthy subjects: 5.65 (4.87) μg/ml; P<0.001). Conclusion: the findings suggest that low plasma adiponectin concentration is associated with atherosclerosis. Plasma concentrations of adiponectin may be related to the pathophysiology role of cardiovascular disease in both CAD and CSF patients.https://www.actamedindones.org/index.php/ijim/article/view/1237Adiponectincoronary artery diseasecoronary slow flow |
| spellingShingle | Muhammad Diah Aznan Lelo Dharma Lindarto Zulfikri Mukhtar Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow Acta Medica Indonesiana Adiponectin coronary artery disease coronary slow flow |
| title | Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow |
| title_full | Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow |
| title_fullStr | Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow |
| title_full_unstemmed | Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow |
| title_short | Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow |
| title_sort | plasma concentrations of adiponectin in patients with coronary artery disease and coronary slow flow |
| topic | Adiponectin coronary artery disease coronary slow flow |
| url | https://www.actamedindones.org/index.php/ijim/article/view/1237 |
| work_keys_str_mv | AT muhammaddiah plasmaconcentrationsofadiponectininpatientswithcoronaryarterydiseaseandcoronaryslowflow AT aznanlelo plasmaconcentrationsofadiponectininpatientswithcoronaryarterydiseaseandcoronaryslowflow AT dharmalindarto plasmaconcentrationsofadiponectininpatientswithcoronaryarterydiseaseandcoronaryslowflow AT zulfikrimukhtar plasmaconcentrationsofadiponectininpatientswithcoronaryarterydiseaseandcoronaryslowflow |